Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis

Free Subscription Articles published in Am J Gastroenterol Retrieve available abstracts of 53 articles: HTML format

Single Articles

March 2023
1. HUR MH, Park MK, Cheuk-Fung Yip T, Chen CH, et al
   Personalized Antiviral Drug Selection in Chronic Hepatitis B Patients Using a Machine Learning Model: A Multinational Study.
   Am J Gastroenterol. 2023 Mar 7. doi: 10.14309/ajg.0000000000002234.
   PubMed     Abstract available
   
   
   January 2023
2. MARTIN P, Jacobson IM
   New Therapies and Management Options for Hepatitis D.
   Am J Gastroenterol. 2023 Jan 30. doi: 10.14309/ajg.0000000000002153.
   PubMed    
   
   
   
3. HIRODE ASG, Hansen BE, Chen CH, Su TH, et al
   Incidence of hepatic decompensation after nucleos(t)ide analogue withdrawal: Results from a large, international, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study).
   Am J Gastroenterol. 2023 Jan 30. doi: 10.14309/ajg.0000000000002203.
   PubMed     Abstract available
   
   
   
4. FELD JJ, Wahed AS, Fried M, Ghany MG, et al
   Withdrawal of long-term nucleotide analogue therapy in chronic hepatitis B: Outcomes from the withdrawal phase of the HBRN immune active treatment trial.
   Am J Gastroenterol. 2023 Jan 13. doi: 10.14309/ajg.0000000000002176.
   PubMed     Abstract available
   
   
   
5. YANG J, Choi WM, Shim JH, Lee D, et al
   Low level of hepatitis B viremia compared with undetectable viremia increases the risk of hepatocellular carcinoma in patients with untreated compensated cirrhosis.
   Am J Gastroenterol. 2023 Jan 9. doi: 10.14309/ajg.0000000000002181.
   PubMed     Abstract available
   
   
   
6. TERRAULT NA, Lok AS, Wahed AS, Ghany MG, et al
   Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B.
   Am J Gastroenterol. 2023 Jan 5. doi: 10.14309/ajg.0000000000002125.
   PubMed     Abstract available
   
   
   
7. JUNG J, Nguyen MH
   Liver-Related Mortality in Hepatitis B Virus Core Antibody+/Hepatitis B Virus Surface Antigen- Patients: Occult Hepatitis B Virus, Hepatitis B Virus Reactivation, and Hepatocellular Carcinoma Development.
   Am J Gastroenterol. 2023;118:24-25.
   PubMed     Abstract available
   
   
   December 2022
8. BUSHYHEAD DW
   Continuing Medical Education Questions: December 2022.
   Am J Gastroenterol. 2022;117:1909.
   PubMed     Abstract available
   
   
   November 2022
9. KRAMER JR, Cao Y, Li L, Smith D, et al
   Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
   Am J Gastroenterol. 2022;117:1834-1844.
   PubMed     Abstract available
   
   
   
10. SHOREIBAH M
    Continuing Medical Education Questions: November 2022.
    Am J Gastroenterol. 2022;117:1742.
    PubMed     Abstract available
    
    
    October 2022
11. YUN B, Oh J, Ahn SH, Yoon JH, et al
    Comparable mortality between Asian chronic hepatitis B patients under long-term antiviral therapy vs. matched control: a population-based study.
    Am J Gastroenterol. 2022 Oct 25. pii: 00000434-990000000-00555.
    PubMed     Abstract available
    
    
    September 2022
12. VELOZ MFG, Han K, Oakes K, Robertson D, et al
    Results of a model of delivering hepatitis C care in a homeless metropolitan population in England.
    Am J Gastroenterol. 2022 Sep 30. pii: 00000434-990000000-00534.
    PubMed     Abstract available
    
    
    
13. SOHN W, Chang Y, Cho YK, Hong YS, et al
    Isolated Hepatitis B core antibody positivity and long-term liver-related mortality in Korea: A cohort study.
    Am J Gastroenterol. 2022 Sep 6. pii: 00000434-990000000-00499.
    PubMed     Abstract available
    
    
    
14. WU S, Zhou J, Wu X, Sun Y, et al
    Comparative Performance of 14 HCC Prediction Models in CHB: A Dynamic Validation at Serial On-Treatment Timepoints.
    Am J Gastroenterol. 2022;117:1444-1453.
    PubMed     Abstract available
    
    
    August 2022
15. SINGH SP, Jindal A, Sharma MK, Sarin SK, et al
    Much more is needed from Hepatitis B Core-related antigen to predict Risk of Liver cancer.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00453.
    PubMed    
    
    
    
16. WONG RJ, Kaufman HW, Niles JK, Chen C, et al
    Low Performance of Hepatitis Delta Virus Testing Among Two National Cohorts of Chronic Hepatitis B Patients in the United States.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00461.
    PubMed     Abstract available
    
    
    
17. LIM N, Kwong AJ, Jafri SM, Jesse MT, et al
    Heterogeneity in Center Practices in Liver Transplantation for Alcohol-associated Liver Disease in the United States.
    Am J Gastroenterol. 2022 Aug 1. pii: 00000434-990000000-00443.
    PubMed     Abstract available
    
    
    July 2022
18. WEINBERG EM, Dukewich M, Jakhete N, Stonesifer E, et al
    Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation.
    Am J Gastroenterol. 2022 Jul 11. pii: 00000434-990000000-00432.
    PubMed     Abstract available
    
    
    
19. GONZALEZ SA, Kamath PS
    Lung Infection in Severe Alcohol-related Hepatitis: Not to be Underestimated.
    Am J Gastroenterol. 2022;117:1044-1045.
    PubMed    
    
    
    June 2022
20. INNES H, Hamill V, McDonald SA, Hayes PC, et al
    Comparing predicted probability of hepatocellular carcinoma in cirrhosis patients to the general population: an opportunity to improve risk communication?
    Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00428.
    PubMed     Abstract available
    
    
    
21. GENG CX, Gudur A, Patterson D, Stotts MJ, et al
    Concordance of ICD-10 Codes and the Clinical Diagnosis of Alcoholic Hepatitis.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00420.
    PubMed     Abstract available
    
    
    
22. CALVARUSO V, Celsam C, D'Ambrosio R, Simone F, et al
    RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00413.
    PubMed     Abstract available
    
    
    
23. FONTANA RJ, Engle RE, Hayashi PH, Gu J, et al
    The Incidence of Hepatitis E infection in American Patients with Suspected Drug-Induced Liver Injury is low and declining: The DILIN Prospective Study.
    Am J Gastroenterol. 2022 Jun 10. pii: 00000434-990000000-00401.
    PubMed     Abstract available
    
    
    May 2022
24. AMPUERO J, Carmona I, Sousa F, Rosales JM, et al
    Correction to: A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure.
    Am J Gastroenterol. 2022;117:819.
    PubMed    
    
    
    
25. MORALES-ARRAEZ D, Ventura-Cots M, Altamirano J, Abraldes JG, et al
    Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
    Am J Gastroenterol. 2022;117:818.
    PubMed    
    
    
    March 2022
26. NTANDJA WANDJI LC, Ningarhari M, Lemaitre E, Khaldi M, et al
    Lung infection impacts access to treatment and short-term outcome in patients with severe alcohol-related hepatitis treated with corticosteroids.
    Am J Gastroenterol. 2022 Mar 28. pii: 00000434-990000000-00311.
    PubMed     Abstract available
    
    
    
27. YUN B, Ahn SH, Yoon JH, Kim BK, et al
    Clinical indication of aspirin associated with reduced risk of liver cancer in chronic hepatitis B: A nationwide cohort study.
    Am J Gastroenterol. 2022 Mar 14. pii: 00000434-990000000-00276.
    PubMed     Abstract available
    
    
    February 2022
28. TSENG TC, Hosaka T, Liu CJ, Suzuki F, et al
    Hepatitis B Core-related Antigen Stratifies the Risk of Liver Cancer in HBeAg-negative Patients with Indeterminate Phase.
    Am J Gastroenterol. 2022 Feb 16. pii: 00000434-990000000-00267.
    PubMed     Abstract available
    
    
    
29. JENA A, Choudhury A, Singh AK
    MELD vs Maddrey Discriminant Function in Alcoholic Hepatitis: The Battle for the Best Score.
    Am J Gastroenterol. 2022 Feb 10. pii: 00000434-990000000-00248.
    PubMed    
    
    
    
30. CHANG R, Chen HY, Wei JC
    Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study.
    Am J Gastroenterol. 2022 Feb 8. pii: 00000434-990000000-00243.
    PubMed    
    
    
    
31. LI J, Henry L, Nguyen MH
    Chronic hepatitis B and fatty liver -weal or woe?
    Am J Gastroenterol. 2022 Feb 2. pii: 00000434-990000000-00238.
    PubMed    
    
    
    January 2022
32. FAYED A, Hegazy MT, Biard L, Vieira M, et al
    Relapse of HCV-Cryoglobulinemic Vasculitis Following Sustained Viral Response after Interferon-free Direct-Acting Antivirals.
    Am J Gastroenterol. 2022 Jan 29. pii: 00000434-990000000-00234.
    PubMed     Abstract available
    
    
    December 2021
33. MORALES-ARRAEZ D, Ventura-Cots M, Altamirano J, Abraldes JG, et al
    The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
    Am J Gastroenterol. 2021 Dec 28. pii: 00000434-990000000-00179.
    PubMed     Abstract available
    
    
    
34. CACOUB P, Asselah T
    Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease.
    Am J Gastroenterol. 2021 Dec 16. pii: 00000434-990000000-00166.
    PubMed     Abstract available
    
    
    October 2021
35. JENSEN MD, Jepsen P, Vilstrup H, Gronbaek L, et al
    Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study.
    Am J Gastroenterol. 2021 Oct 8. pii: 00000434-990000000-00120.
    PubMed     Abstract available
    
    
    
36. LI J, Le MH, Barakat MT, Cheung RC, et al
    The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016.
    Am J Gastroenterol. 2021;116:2068-2078.
    PubMed     Abstract available
    
    
    September 2021
37. LEE HW, Park SY, Lee YR, Lee H, et al
    Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00096.
    PubMed     Abstract available
    
    
    
38. AMPUERO J, Carmona I, Sousa F, Rosales JM, et al
    A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure.
    Am J Gastroenterol. 2021 Sep 9. pii: 00000434-900000000-98663.
    PubMed     Abstract available
    
    
    
39. CHUANG WL, Hu TH, Buggisch P, Moreno C, et al
    Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease.
    Am J Gastroenterol. 2021;116:1924-1928.
    PubMed     Abstract available
    
    
    
40. ZAMOR PJ, Brown A, Dylla DE, Dillon JF, et al
    High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.
    Am J Gastroenterol. 2021;116:1896-1904.
    PubMed     Abstract available
    
    
    August 2021
41. KONSTANTELOS N, Shakeri A, McCormack D, Feld JJ, et al
    Impact of COVID-19 on Prescribing Trends of Direct-Acting Antivirals for the Treatment of Hepatitis C in Ontario, Canada.
    Am J Gastroenterol. 2021;116:1738-1740.
    PubMed     Abstract available
    
    
    June 2021
42. SCHAEFER EAK
    A Deep Ravine Rather Than a Shallow Gap: Many More Bridges Needed to Improve Care of Chronic Hepatitis B in the United States.
    Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00023.
    PubMed     Abstract available
    
    
    
43. YU X
    Pay Attention to Distinguish Hepatitis from Novel Coronavirus Hepatitis in the Context of COVID-19 Pandemic.
    Am J Gastroenterol. 2021;116:1354-1355.
    PubMed    
    
    
    
44. RINALDI L, Messina V, Di Marco V, Iovinella V, et al
    Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience.
    Am J Gastroenterol. 2021;116:1248-1255.
    PubMed     Abstract available
    
    
    
45. NGUYEN MH, Atsukawa M, Ishikawa T, Yasuda S, et al
    Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir.
    Am J Gastroenterol. 2021;116:1264-1273.
    PubMed     Abstract available
    
    
    April 2021
46. TRAN S, Jeong D, Henry L, Cheung RC, et al
    Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
    PubMed     Abstract available
    
    
    
47. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
    PubMed    
    
    
    
48. JI D, Chen Y, Shang Q, Liu H, et al
    Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98824.
    PubMed     Abstract available
    
    
    
49. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    PubMed     Abstract available
    
    
    
50. EISA M, Kennedy R, Teferra R, Heckroth M, et al
    SARS-COV-2 Infection in Patients With Alcohol-Associated Hepatitis: Metabolic Similarities and Treatment Challenges.
    Am J Gastroenterol. 2021;116:847-848.
    PubMed    
    
    
    March 2021
51. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    PubMed     Abstract available
    
    
    
52. WONG RJ, Jain MK, Therapondos G, Niu B, et al
    Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
    Am J Gastroenterol. 2021 Mar 1. pii: 00000434-900000000-98873.
    PubMed     Abstract available
    
    
    February 2021
53. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: